rs147293270

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_000263.4(NAGLU):​c.1438G>A​(p.Ala480Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00103 in 1,597,670 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00083 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0010 ( 3 hom. )

Consequence

NAGLU
NM_000263.4 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:7B:1

Conservation

PhyloP100: 0.190
Variant links:
Genes affected
NAGLU (HGNC:7632): (N-acetyl-alpha-glucosaminidase) This gene encodes an enzyme that degrades heparan sulfate by hydrolysis of terminal N-acetyl-D-glucosamine residues in N-acetyl-alpha-D-glucosaminides. Defects in this gene are the cause of mucopolysaccharidosis type IIIB (MPS-IIIB), also known as Sanfilippo syndrome B. This disease is characterized by the lysosomal accumulation and urinary excretion of heparan sulfate. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.018946618).
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000833 (127/152390) while in subpopulation NFE AF= 0.00126 (86/68034). AF 95% confidence interval is 0.00105. There are 0 homozygotes in gnomad4. There are 69 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NAGLUNM_000263.4 linkuse as main transcriptc.1438G>A p.Ala480Thr missense_variant 6/6 ENST00000225927.7 NP_000254.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NAGLUENST00000225927.7 linkuse as main transcriptc.1438G>A p.Ala480Thr missense_variant 6/61 NM_000263.4 ENSP00000225927 P1
NAGLUENST00000591587.1 linkuse as main transcriptc.*407G>A 3_prime_UTR_variant 4/45 ENSP00000467836
NAGLUENST00000592454.1 linkuse as main transcriptc.*281G>A 3_prime_UTR_variant 2/22 ENSP00000468665

Frequencies

GnomAD3 genomes
AF:
0.000834
AC:
127
AN:
152272
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000410
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00126
Gnomad OTH
AF:
0.000956
GnomAD3 exomes
AF:
0.000742
AC:
163
AN:
219550
Hom.:
0
AF XY:
0.000778
AC XY:
93
AN XY:
119500
show subpopulations
Gnomad AFR exome
AF:
0.000364
Gnomad AMR exome
AF:
0.000350
Gnomad ASJ exome
AF:
0.00211
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000141
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00121
Gnomad OTH exome
AF:
0.000725
GnomAD4 exome
AF:
0.00105
AC:
1517
AN:
1445280
Hom.:
3
Cov.:
32
AF XY:
0.00109
AC XY:
781
AN XY:
718100
show subpopulations
Gnomad4 AFR exome
AF:
0.000241
Gnomad4 AMR exome
AF:
0.000543
Gnomad4 ASJ exome
AF:
0.00197
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000828
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00125
Gnomad4 OTH exome
AF:
0.000719
GnomAD4 genome
AF:
0.000833
AC:
127
AN:
152390
Hom.:
0
Cov.:
33
AF XY:
0.000926
AC XY:
69
AN XY:
74516
show subpopulations
Gnomad4 AFR
AF:
0.000409
Gnomad4 AMR
AF:
0.00118
Gnomad4 ASJ
AF:
0.00115
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00126
Gnomad4 OTH
AF:
0.000946
Alfa
AF:
0.00111
Hom.:
0
Bravo
AF:
0.000858
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00208
AC:
8
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00151
AC:
13
ExAC
AF:
0.000751
AC:
91
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:7Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:4
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMar 01, 2023- -
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Aug 24, 2016- -
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicJun 12, 2020- -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxNov 04, 2020Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function -
Mucopolysaccharidosis, MPS-III-B;C5569050:Charcot-Marie-Tooth disease axonal type 2V Uncertain:1Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 31, 2018- -
Mucopolysaccharidosis, MPS-III-B Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Intellectual disability Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingCentre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de LilleJan 01, 2019- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
3.6
DANN
Benign
0.56
DEOGEN2
Uncertain
0.55
D
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.085
N
LIST_S2
Benign
0.28
T
M_CAP
Benign
0.079
D
MetaRNN
Benign
0.019
T
MetaSVM
Uncertain
0.41
D
MutationAssessor
Benign
1.0
L
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.28
T
PROVEAN
Benign
0.26
N
REVEL
Benign
0.19
Sift
Benign
0.81
T
Sift4G
Benign
0.60
T
Polyphen
0.038
B
Vest4
0.054
MVP
0.70
MPC
0.36
ClinPred
0.00095
T
GERP RS
-0.77
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.040
gMVP
0.32

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs147293270; hg19: chr17-40695462; API